Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Novel protein pathway linked to aggressive progression of breast cancer
December 23rd, 2004
Cytogen Corp. (CYTO), a product-driven biopharmaceutical company, announced the publication of a study linking a novel protein pathway to the aggressive progression of breast cancer. "Starting with any protein known to contain structurally and functionally defined signaling modules and/or their respective binding partners, researchers can rapidly identify potential interacting proteins using Cytogen's proprietary database," said Michael D. Becker, Cytogen's president and CEO. "Unlike other approaches that may require both complex and resource-intensive genomic and proteomic tools to identify qualified novel targets for drug discovery, this data can...
Source: Women's Health Weekly (2004-12-23)
|
